# Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

> **NCT04526886** · NA · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 52 (actual)

## Conditions studied

- Colorectal Cancer
- Gastric Cancer
- Esophageal Cancer
- Ampullary Cancer
- Small Bowel Cancer
- Appendix Cancer

## Interventions

- **OTHER:** Algorithm for cytopenia-related delay and dose-reduction of mFOLFOX chemotherapy

## Key facts

- **NCT ID:** NCT04526886
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2023-03-07
- **Final completion:** 2023-03-07
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04526886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04526886, "Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04526886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*